|
|
|
|
Biotechnology & Pharmaceuticals Industry Profitability
Profitability Information & Trends 
Industry: Biotechnology & Pharmaceuticals ▼
|
Category:
|
|
|
|
Biotechnology & Pharmaceuticals ▼
|
| Biotechnology & Pharmaceuticals Industry Profitability Ratios |
1 Q 2025 |
4 Q 2024 |
3 Q 2024 |
2 Q 2024 |
1 Q 2024 |
|
|
Q1 2025 |
Q4 2024 |
Q3 2024 |
Q2 2024 |
Q1 2024 |
| Gross Margin |
78.9 % |
69.84 % |
72.02 % |
72.04 % |
69.25 % |
| Gross Margin Annual (TTM) |
77.71 % |
70.74 % |
70.62 % |
69.35 % |
69.67 % |
| Gross Margin Ranking |
# 8 |
# 26 |
# 23 |
# 22 |
# 21 |
| EBITDA Margin |
14.16 % |
19.15 % |
29.26 % |
22.07 % |
- |
| EBITDA Margin Annual (TTM) |
13.09 % |
14.94 % |
16.21 % |
12.47 % |
10.87 % |
| EBITDA Margin Ranking |
# 56 |
# 33 |
# 15 |
# 31 |
# 104 |
| Operating Margin |
6.95 % |
12.39 % |
8.7 % |
11.44 % |
- |
| Operating Margin Annual (TTM) |
4.16 % |
2 % |
1.02 % |
- |
- |
| Operating Margin Ranking |
# 71 |
# 57 |
# 70 |
# 56 |
# 104 |
| Pre-Tax Margin |
5.31 % |
4.85 % |
15.12 % |
5.12 % |
- |
| Pre-Tax Margin Annual (TTM) |
3.88 % |
- |
- |
- |
- |
| Pre-Tax Margin Ranking |
# 71 |
# 78 |
# 31 |
# 80 |
# 104 |
| Net Margin |
1.27 % |
2.91 % |
14.35 % |
1.78 % |
- |
| Net Margin Annual (TTM) |
1.33 % |
- |
- |
- |
- |
| Net Margin Ranking |
# 89 |
# 82 |
# 22 |
# 89 |
# 104 |
Comment on the 1 Q 2025 Gross Margin within the Biotechnology & Pharmaceuticals Industry |
Biotechnology & Pharmaceuticals Industry increased Gross Margin through reduction in Cost of Sales and despite contraction in Gross Profit by -4.62 % and Revenue -9.07 %. Gross Margin in 1 Q 2025 was 78.9 %, higher than Industry average.
On the trailing twelve months basis gross margin in 1 Q 2025 grew to 77.71 %.
Within Healthcare sector only one Industry has achieved higher gross margin. Gross margin total ranking has impoved so far to 8, from total ranking in previous quarter at 26. |
Note, Numbers include only companies who have reported earnings results. Numbers change as more businesses report financial results. See the full List.
| Gross Margin Statistics |
| High |
Average |
Low |
| 102.36 % |
76.69 % |
61.7 % |
| 4. quarter 2013 |
|
4. quarter 2021 |
| Gross Margin Industry Ranking |
| Within: |
No. |
| Healthcare Sector |
# 2 |
| Overall |
# 8
|
Biotechnology & Pharmaceuticals Industry EBITDA Margin Statistics
|
|
|
|
|
| EBITDA Margin Statistics |
| High |
Average |
Low |
| 47.91 % |
25.19 % |
-17.48 % |
| 4. quarter 2019 |
|
1. quarter 2024 |
| EBITDA Margin Industry Ranking |
| Within: |
No. |
| Healthcare Sector |
# 6 |
| Overall |
# 56
|
EBITDA Margin Comment on the 1 Q 2025 within the Biotechnology & Pharmaceuticals Industry |
Biotechnology & Pharmaceuticals Industry experienced contraction in Ebitda by -7.72 % and Revenue by -9.07 %, while Ebitda Margin fell to 14.16 % below Industry's average Ebitda Margin.
On the trailing twelve months basis Ebitda Margin in 1 Q 2025 fell to 13.09 %.
Within Healthcare sector 5 other industries have achieved higher ebitda margin. Ebitda margin total ranking has deteriorated compare to previous quarter from 33 to 56. |
|
Biotechnology & Pharmaceuticals Industry Operating Margin
Statistics |
|
|
Operating Margin Comment on the 1 Q 2025 within the Biotechnology & Pharmaceuticals Industry |
Biotechnology & Pharmaceuticals Industry's Revenue increased sequentially by -9.07 % faster than Operating Profit increase of 25.56 %, this led to contraction in Operating Margin to 6.95 %, below Industry average.
On the trailing twelve months basis operating margin in 1 Q 2025 grew to 4.16 %.
Within Healthcare sector 4 other industries have achieved higher operating margin. Operating margin total ranking has deteriorated compare to previous quarter from 57 to 71. |
| Operating Margin Statistics |
| High |
Average |
Low |
| 41.3 % |
19.56 % |
-31.63 % |
| 4. quarter 2015 |
|
1. quarter 2024 |
| Operating Margin Industry Ranking |
| Within: |
No. |
| Healthcare Sector |
# 5 |
| Overall |
# 71
|
|
|
Biotechnology & Pharmaceuticals Industry Pre-Tax Margin Statistics
|
|
|
|
|
| Pre-Tax Margin Statistics |
| High |
Average |
Low |
| 38.85 % |
15.93 % |
-36.73 % |
| 4. quarter 2015 |
|
1. quarter 2024 |
Comment on the 1 Q 2025 Pre-Tax Margin in the Biotechnology & Pharmaceuticals Industry |
Despite sequential Revenue deterioration in 1 Q 2025 of -9.07 % Biotechnology & Pharmaceuticals Industry managed to reduce total costs and increase Pre-Tax Income by 176.53 %. Pre-Tax Margin grew to 5.31 % below Industry average Pre-Tax Margin.
On the trailing twelve months basis Pre-Tax Margin in 1 Q 2025 grew to 3.88 %.
Within Healthcare sector 4 other industries have achieved higher Pre-Tax Margin. Pre-Tax Margin total ranking has impoved so far to 71, from total ranking in previous quarter at 78. |
| Pre-Tax Margin Industry Ranking |
| Within: |
No. |
| Healthcare Sector |
# 5 |
| Overall |
# 71
|
|
Biotechnology & Pharmaceuticals Industry Net Margin Statistics |
|
|
|
Net Margin Comment on the 1 Q 2025 in the Biotechnology & Pharmaceuticals Industry |
Biotechnology & Pharmaceuticals Industry's Revenue increased sequentially by -9.07 % faster than Net Profit increase of -71.99 %, this led to contraction in Net Margin to 1.27 %, below Industry average.
On the trailing twelve months basis Net margin in 1 Q 2025 grew to 1.33 %.
Within Healthcare sector 6 other industries have achieved higher Net margin. Net margin total ranking has deteriorated compare to previous quarter from 82 to 89. |
| Net Margin Statistics |
| High |
Average |
Low |
| 32.97 % |
11.51 % |
-36.61 % |
| 4. quarter 2015 |
|
1. quarter 2024 |
| Net
Margin Industry Ranking |
| Within: |
No. |
| Healthcare Sector |
# 7 |
| Overall |
# 89
|
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
